Ilse De Coster

1.1k total citations
22 papers, 640 citations indexed

About

Ilse De Coster is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Ilse De Coster has authored 22 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in Ilse De Coster's work include Viral gastroenteritis research and epidemiology (11 papers), Viral Infections and Immunology Research (10 papers) and Hepatitis B Virus Studies (6 papers). Ilse De Coster is often cited by papers focused on Viral gastroenteritis research and epidemiology (11 papers), Viral Infections and Immunology Research (10 papers) and Hepatitis B Virus Studies (6 papers). Ilse De Coster collaborates with scholars based in Belgium, United States and United Kingdom. Ilse De Coster's co-authors include Pierre Van Damme, Ananda S Bandyopadhyay, Rahnuma Wahid, John Konz, Alex Vorsters, Margareta Ieven, Hilde Revets, Joanne Wolter, Lisa Lindsay and Thomas Verstraeten and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ilse De Coster

21 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilse De Coster Belgium	13	386	231	209	108	70	22	640
Danit Sofer Israel	17	800 2.1×	201 0.9×	483 2.3×	137 1.3×	42 0.6×	51	1.0k
Charlotte A. Moser United States	12	250 0.6×	132 0.6×	82 0.4×	59 0.5×	71 1.0×	39	507
Sanjoy Datta Belgium	14	238 0.6×	454 2.0×	114 0.5×	46 0.4×	116 1.7×	20	764
Rajeev Dhere India	16	339 0.9×	500 2.2×	75 0.4×	122 1.1×	95 1.4×	60	868
Changying Lin China	13	262 0.7×	251 1.1×	67 0.3×	47 0.4×	46 0.7×	28	708
Ramona Trebbien Denmark	22	460 1.2×	795 3.4×	70 0.3×	125 1.2×	103 1.5×	66	1.1k
Kamol Suwannakarn Thailand	18	488 1.3×	634 2.7×	191 0.9×	114 1.1×	44 0.6×	44	985
Laurence Chu United States	13	391 1.0×	255 1.1×	53 0.3×	143 1.3×	109 1.6×	22	656
Ayan Dey India	15	383 1.0×	219 0.9×	30 0.1×	178 1.6×	166 2.4×	25	816
Doris Chibo Australia	17	461 1.2×	578 2.5×	70 0.3×	57 0.5×	106 1.5×	36	894

Countries citing papers authored by Ilse De Coster

Since Specialization

Citations

This map shows the geographic impact of Ilse De Coster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse De Coster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse De Coster more than expected).

Fields of papers citing papers by Ilse De Coster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse De Coster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse De Coster. The network helps show where Ilse De Coster may publish in the future.

Co-authorship network of co-authors of Ilse De Coster

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse De Coster. A scholar is included among the top collaborators of Ilse De Coster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse De Coster. Ilse De Coster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brickley, Elizabeth B., Ruth I. Connor, Wendy Wieland‐Alter, et al.. (2025). Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials. The Lancet Microbe. 6(6). 101028–101028. 1 indexed citations

Giuliano, Anna R., Joel M. Palefsky, Stephen E. Goldstone, et al.. (2025). Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies. Human Vaccines & Immunotherapeutics. 21(1). 2425146–2425146. 1 indexed citations

Steenackers, Katie, Nikita Hanning, Liesbeth Bruckers, et al.. (2024). Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial. Vaccine. 42(25). 126117–126117. 1 indexed citations

Pattyn, Jade, Severien Van Keer, Ilse De Coster, et al.. (2023). Follow‐up of humoral immune response after HPV vaccination using first‐void urine: A longitudinal cohort study. Journal of Medical Virology. 95(10). e29133–e29133. 5 indexed citations

Coster, Ilse De, Kanchanamala Withanage, Laina D. Mercer, et al.. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine. 41(10). 1657–1667. 5 indexed citations

Tschismarov, Roland, Pierre Van Damme, Ilse De Coster, et al.. (2023). Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial. The Lancet. 401(10384). 1267–1276. 21 indexed citations

Wahid, Rahnuma, Laina D. Mercer, Andrew Macadam, et al.. (2021). Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. npj Vaccines. 6(1). 94–94. 13 indexed citations

Coster, Ilse De, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, et al.. (2020). Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. The Lancet. 397(10268). 39–50. 58 indexed citations

Yeh, Ming Te, Erika Bujáki, Patrick Dolan, et al.. (2020). Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence. Cell Host & Microbe. 27(5). 736–751.e8. 136 indexed citations

10.

Brickley, Elizabeth B., Ruth I. Connor, Wendy Wieland‐Alter, et al.. (2020). Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium. The Journal of Infectious Diseases. 226(2). 287–291. 8 indexed citations

11.

Damme, Pierre Van, Ilse De Coster, Ananda S Bandyopadhyay, et al.. (2019). Poliopolis: Pushing Boundaries of Scientific Innovations for Disease Eradication. Future Microbiology. 14(15). 1321–1330. 6 indexed citations

12.

Leroux‐Roels, Geert, Jakob P. Cramer, Paul M. Mendelman, et al.. (2017). Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial. The Journal of Infectious Diseases. 217(4). 597–607. 57 indexed citations

13.

Damme, Pierre Van, Ilse De Coster, Christophe Depuydt, et al.. (2016). GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial. Clinical Cancer Research. 22(13). 3238–3248. 34 indexed citations

14.

Vorsters, Alex, Severien Van Keer, Ilse De Coster, et al.. (2016). Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing. International Journal of Molecular Sciences. 17(5). 750–750. 18 indexed citations

15.

Lindsay, Lisa, Joanne Wolter, Ilse De Coster, Pierre Van Damme, & Thomas Verstraeten. (2015). A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review. BMC Infectious Diseases. 15(1). 425–425. 55 indexed citations

16.

Coster, Ilse De, et al.. (2015). Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study. Vaccine. 33(32). 3976–3982. 37 indexed citations

17.

Herck, Koen Van, Ilse De Coster, André Vertruyen, et al.. (2014). Long-term Antibody Persistence in Children After Vaccination With the Pediatric Formulation of an Aluminum-free Virosomal Hepatitis A Vaccine. The Pediatric Infectious Disease Journal. 34(4). e85–e91. 12 indexed citations

18.

Vorsters, Alex, Joeri van den Bergh, Johannes Bogers, et al.. (2014). Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. European Journal of Clinical Microbiology & Infectious Diseases. 33(11). 2005–2014. 86 indexed citations

19.

Coster, Ilse De, et al.. (2014). O-147a Assessment Of Preparation Time With Fully Liquid Versus Reconstituted Paediatric Hexavalent Vaccines. A Time And Motion Study. Archives of Disease in Childhood. 99(Suppl 2). A80.2–A81. 1 indexed citations

20.

Damme, Pierre Van, Alessandra Anemona, Anne Katrin Hilbert, et al.. (2011). Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults. PLoS ONE. 6(9). e25398–e25398. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact